NCT03910478View on ClinicalTrials.gov

Dried Blood Spot Testing of CMV Detection in HCT Recipients

NACompletedINTERVENTIONAL
Enrollment

622

Participants

Timeline

Start Date

May 3, 2019

Primary Completion Date

January 16, 2024

Study Completion Date

January 16, 2024

Conditions
Cytomegalovirus Infection
Interventions
DEVICE

DBS Self-Collection Kit

Kit for self-collection of Dried Blood Spot (DBS) samples

OTHER

Standard Control Strategy

Standard of care with office-based testing.

Trial Locations (4)

55455-0356

University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine, Minneapolis

10065-6007

Memorial Sloan Kettering Cancer Center, New York

77030-4000

The University of Texas - MD Anderson Cancer Center - Infectious Diseases, Houston

98109-4433

Fred Hutchinson Cancer Research Center - Vaccine and Infectious Diseases, Seattle

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03910478 - Dried Blood Spot Testing of CMV Detection in HCT Recipients | Biotech Hunter | Biotech Hunter